Literature DB >> 28634666

CT Density in the Pancreas is a Promising Imaging Predictor for Pancreatic Ductal Adenocarcinoma.

Yasunari Fukuda1, Daisaku Yamada1, Hidetoshi Eguchi2, Tomoki Hata1, Yoshifumi Iwagami1, Takehiro Noda1, Tadafumi Asaoka1, Koichi Kawamoto1, Kunihito Gotoh1, Shogo Kobayashi1, Yutaka Takeda1,3, Masahiro Tanemura1,4, Masaki Mori1, Yuichiro Doki1.   

Abstract

BACKGROUND: Fatty pancreas (FP) was recently recognized as a risk factor for pancreatic ductal adenocarcinoma (PDAC). It is unclear whether computed tomography (CT) can be used to make a FP diagnosis. This study investigated whether CT could provide a predictive value for PDAC by diagnosing FP.
METHODS: The study included 183 consecutive patients who underwent distal pancreatectomy from February 2007 to January 2017, including 75 cases of PDAC and 108 cases of other pancreatic disease. Pancreatic CT density (pancreatic index; PI) at the initial diagnosis was calculated by dividing the CT number in the pancreas by the number in the spleen. To assess whether CT could be used to detect FP, 43 cases were evaluated pathologically for FP. We investigated the correlation between FP and PI, and determined the optimal PI cutoff value for detecting FP using receiver operating characteristics analysis. We then investigated whether the PI value could be used as a predictor for PDAC.
RESULTS: Fourteen cases (32.6%) were pathologically diagnosed with FP. PI was significantly lower in the FP group versus the non-FP group (0.51 vs. 0.83; p = 0.0049). ROC analysis indicated that the PI had good diagnostic accuracy for FP diagnosis (cutoff value 0.70; sensitivity 0.79, specificity 0.79). Low PI (≤0.70) was identified in the multivariate analysis as an independent risk factor for PDAC (odds ratio 2.31; p = 0.023).
CONCLUSIONS: PI was strongly associated with pathological FP, which was independently associated with PDAC. PI shows promise as an imaging predictor for PDAC.

Entities:  

Mesh:

Year:  2017        PMID: 28634666     DOI: 10.1245/s10434-017-5914-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  8 in total

1.  Evaluation of pancreatic steatosis prevalence and anthropometric measurements using non-contrast computed tomography.

Authors:  Ural Koç; Onur Taydaş
Journal:  Turk J Gastroenterol       Date:  2020-09       Impact factor: 1.852

Review 2.  Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, "Prediabetes," Diabetes and Atherosclerosis.

Authors:  T D Filippatos; K Alexakis; V Mavrikaki; D P Mikhailidis
Journal:  Dig Dis Sci       Date:  2021-01-19       Impact factor: 3.199

3.  Computed Tomography-Estimated Pancreatic Steatosis is Associated with Carotid Plaque in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study from China.

Authors:  Pengtao Sun; Chunzhi Fan; Rengui Wang; Tongwei Chu; Xiaoli Sun; Dongxue Zhang; Xuechao Du
Journal:  Diabetes Metab Syndr Obes       Date:  2021-03-22       Impact factor: 3.168

4.  Hyperdense Pancreatic Ductal Adenocarcinoma: Clinical Characteristics and Proteomic Landscape.

Authors:  He Xu; Jie Hua; Qingcai Meng; Xiaohong Wang; Jin Xu; Wei Wang; Bo Zhang; Jiang Liu; Chen Liang; Xianjun Yu; Si Shi
Journal:  Front Oncol       Date:  2021-02-25       Impact factor: 6.244

5.  Computed tomography evaluation of pancreatic steatosis: correlation with COVID-19 prognosis.

Authors:  Serkan Guneyli; Hakan Dogan; Omer Tarik Esengur; Hur Hassoy
Journal:  Future Virol       Date:  2021-02-10       Impact factor: 1.831

Review 6.  Uniting epidemiology and experimental models: pancreatic steatosis and pancreatic cancer.

Authors:  Emily Truong; Stephen Pandol; Christie Jeon
Journal:  EBioMedicine       Date:  2022-04-08       Impact factor: 11.205

7.  Pancreatic Fat Infiltration Is Associated with a Higher Risk of Pancreatic Ductal Adenocarcinoma.

Authors:  Vishal Desai; Kevin Patel; Ravi Sheth; Usman Barlass; Yuet-Ming Chan; Joy Sclamberg; Faraz Bishehsari
Journal:  Visc Med       Date:  2020-05-05

Review 8.  Fatty Pancreas-Centered Metabolic Basis of Pancreatic Adenocarcinoma: From Obesity, Diabetes and Pancreatitis to Oncogenesis.

Authors:  Ming-Ling Chang
Journal:  Biomedicines       Date:  2022-03-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.